-
Mr Xu Jinghe Attends the “CIMDR - GHWP Session & International Drug Regulatory Authorities Dialogue”
On the evening of December 20, 2022, the "China International Medical Device Regulatory Forum (CIMDR) - Global Harmonization Working Party (GHWP) Session & International Drug Regulatory Authorities Dialogue" was held online. Mr Xu Jinghe, Deputy Commissioner of the National Medical Products Administration (NMPA), attended the meeting online and delivered keynote speech.
-
China has 13 COVID vaccines available for second booster
A total of 13 types of COVID-19 vaccines, approved for conditional marketing or emergency use, are now available as a second booster dose in China, according to experts with the State Council inter-agency task force for COVID-19 response.
-
China has 13 COVID vaccines available for second booster
A total of 13 types of COVID-19 vaccines, approved for conditional marketing or emergency use, are now available as a second booster dose in China, according to experts with the State Council inter-agency task force for COVID-19 response.
- Provisions for Supervision and Administration of Online Drug Sales
- NMPA Announcement on putting into use the electronic certificates of Documentation for Export of APIs to EU and Certificate of a Pharmaceutical Product
- Provisions for Supervision and Administration of Manufacturing and Marketing of Cosmetics
- Announcement of the Center for Food and Drug Inspection of NMPA on Issuing 5 Documents including the Work Procedures for Drug Registration Inspection (Trial) (No. 30 of 2021)
- NMPA Announcement on Issuing the List of Medical Devices Prohibited from Contract Manufacturing
- NMPA Announcement on Issuing the Guidance for the Preparation of Annual Self-inspection Report of Medical Device Quality Management System
